Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial

Therapies for breast cancer may induce hot flashes that can affect quality of life. We undertook a double-blind, placebo-controlled trial with the primary objective of comparing the average daily hot flash scores in the twelfth week among patients treated with venlafaxine, clonidine, and placebo. Ad...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2011-10, Vol.29 (29), p.3862-3868
Hauptverfasser:	BOEKHOUT, Annelies H, VINCENT, Andrew D, DALESIO, Otilia B, DEN BOSCH, Joan Van, FOEKEMA-TÖNS, Joke H, ADRIAANSZ, Sandra, SPRANGERS, Sylvia, NUIJEN, Bastiaan, BEIJNEN, Jos H, SCHELLENS, Jan H. M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Analgesics - therapeutic use Biological and medical sciences Breast Neoplasms - complications Breast Neoplasms - drug therapy Clonidine - therapeutic use Cyclohexanols - therapeutic use Double-Blind Method Drug toxicity and drugs side effects treatment Female Hot Flashes - chemically induced Hot Flashes - drug therapy Hot Flashes - etiology Humans Medical sciences Middle Aged Pharmacology. Drug treatments Placebos Serotonin Uptake Inhibitors - therapeutic use Toxicity: cardiovascular system Treatment Outcome Tumors Venlafaxine Hydrochloride
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!